JP2019500056A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500056A5 JP2019500056A5 JP2018543445A JP2018543445A JP2019500056A5 JP 2019500056 A5 JP2019500056 A5 JP 2019500056A5 JP 2018543445 A JP2018543445 A JP 2018543445A JP 2018543445 A JP2018543445 A JP 2018543445A JP 2019500056 A5 JP2019500056 A5 JP 2019500056A5
- Authority
- JP
- Japan
- Prior art keywords
- fermentation composition
- plant material
- composition according
- algae
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 238000000855 fermentation Methods 0.000 claims 15
- 230000004151 fermentation Effects 0.000 claims 15
- 241000196324 Embryophyta Species 0.000 claims 9
- 239000000463 material Substances 0.000 claims 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 7
- 235000014655 lactic acid Nutrition 0.000 claims 7
- 239000004310 lactic acid Substances 0.000 claims 7
- 241000894006 Bacteria Species 0.000 claims 6
- 241001474374 Blennius Species 0.000 claims 6
- 241000195493 Cryptophyta Species 0.000 claims 6
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims 6
- 241000219198 Brassica Species 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 240000005158 Phaseolus vulgaris Species 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 206010073080 Autoinflammatory disease Diseases 0.000 claims 2
- 208000008035 Back Pain Diseases 0.000 claims 2
- 206010060945 Bacterial infection Diseases 0.000 claims 2
- 235000011331 Brassica Nutrition 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 206010016256 Fatigue Diseases 0.000 claims 2
- 240000007842 Glycine max Species 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 2
- 240000006669 Helianthus annuus Species 0.000 claims 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 208000001072 Type 2 Diabetes Mellitus Diseases 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 2
- 201000008286 diarrhea Diseases 0.000 claims 2
- 229940079593 drugs Drugs 0.000 claims 2
- 235000005489 dwarf bean Nutrition 0.000 claims 2
- 235000002096 horsebean Nutrition 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000003638 reducing agent Substances 0.000 claims 2
- 238000011105 stabilization Methods 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 1
- 241000194033 Enterococcus Species 0.000 claims 1
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 229940039696 Lactobacillus Drugs 0.000 claims 1
- 241000194036 Lactococcus Species 0.000 claims 1
- 206010067125 Liver injury Diseases 0.000 claims 1
- 241000219745 Lupinus Species 0.000 claims 1
- 240000007817 Olea europaea Species 0.000 claims 1
- 241000192001 Pediococcus Species 0.000 claims 1
- 241000199919 Phaeophyceae Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 241000206572 Rhodophyta Species 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 208000006641 Skin Disease Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 239000003529 anticholesteremic agent Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 231100000234 hepatic damage Toxicity 0.000 claims 1
- 239000005555 hypertensive agent Substances 0.000 claims 1
- 230000001568 sexual Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Claims (15)
- 少なくとも１種の植物材料；海藻又は藻類；及び１種又は複数の乳酸菌株を含む、医薬品として使用するための発酵組成物。
- 植物材料と海藻又は藻類との組み合わせ；及び１種又は複数の乳酸菌株を含む、哺乳動物における腸誘発疾患の治療、緩和、安定化、又は予防に使用するための発酵組成物。
- 前記哺乳動物における腸誘発疾患が、自己炎症性疾患；硬化症；アレルギー又は不耐性；便秘；腸内細菌叢の活性化；疲労、炎症、下痢；出生前後の乳児腸内細菌叢の刺激；炎症性腸疾患、細菌感染症、皮膚疾患、２型糖尿病、及び／又はＸ線で確認されるモディック変化（Ｍｏｄｉｃ ｃｈａｎｇｅ）（Ｉ及びＩＩ）を伴う又は伴わない背痛からなる群から選択され得る、請求項２に記載の発酵組成物。
- 前記植物材料が、アブラナ属（Ｂｒａｓｓｉｃａ）種；ヒマワリ；パーム；ダイズ、フィールドビーンズ、ハウチワマメ；又はこれらの組み合わせの少なくとも１つから選択される、請求項２又は３に記載の発酵組成物。
- 前記植物材料がアブラナ属（Ｂｒａｓｓｉｃａ）種である、請求項２〜４のいずれか１項に記載の発酵組成物。
- 自己炎症性疾患；硬化症；アレルギー又は不耐性；便秘；腸内細菌叢の活性化；疲労、炎症、下痢；出生前後の乳児腸内細菌叢の刺激；炎症性腸疾患、細菌感染症、皮膚疾患、２型糖尿病、及び／又はＸ線で確認されるモディック変化（Ｍｏｄｉｃ ｃｈａｎｇｅ）（Ｉ及びＩＩ）を伴う又は伴わない背痛の治療、緩和、安定化、又は予防に使用するための発酵組成物であって、少なくとも１種の植物材料；海藻又は藻類；及び１種又は複数の乳酸菌株を含む、発酵組成物。
- 前記植物材料が、アブラナ属（Ｂｒａｓｓｉｃａ）種；ヒマワリ；パーム；ダイズ、フィールドビーンズ、ハウチワマメ；又はこれらの組み合わせの少なくとも１つから選択される、請求項６に記載の発酵組成物。
- 前記植物材料がアブラナ属（Ｂｒａｓｓｉｃａ）種である、請求項１〜７のいずれか１項に記載の発酵組成物。
- 少なくとも１種の植物材料；海藻又は藻類；及び１種又は複数の乳酸菌株を含む、血中コレステロール減少剤、トリグリセリド減少剤、肝損傷の減少、及び／又は高血圧低下剤として使用するための発酵組成物。
- １種又は複数の他の薬物を伴うアジュバント製品である、請求項１〜１２のいずれか１項に記載の発酵組成物。
- ｐＨ６．５未満のｐＨ値を有する、請求項１〜１０のいずれか１項に記載の発酵組成物。
- 少なくとも５０ｍＭの乳酸濃度を有する、請求項１〜１１のいずれか１項に記載の発酵組成物。
- 前記海藻及び／又は藻類が、褐藻類、紅藻類、及び緑藻類の１又は複数から選択される、請求項１〜１２のいずれか１項に記載の発酵組成物。
- 前記１種又は複数の乳酸菌が、エンテロコッカス属、ラクトバチルス属、ペディオコッカス属及びラクトコッカス属、並びにこれらの組み合わせからなる群から選択される、請求項１〜１３のいずれか１項に記載の発酵組成物。
- （ａ）少なくとも１種の植物材料；海藻又は藻類；及び１種又は複数の乳酸菌株を含む発酵組成物又は請求項１〜１４のいずれか１項に記載の発酵組成物と；
（ｂ）１種又は複数の薬物と
を含む、組み合わせ製品。
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201500700 | 2015-11-08 | ||
| DKPA201500700 | 2015-11-08 | ||
| DKPA201600128 | 2016-02-29 | ||
| DKPA201600128 | 2016-02-29 | ||
| DKPA201600431 | 2016-07-20 | ||
| DKPA201600431 | 2016-07-20 | ||
| DKPA201600537 | 2016-09-14 | ||
| DKPA201600537 | 2016-09-14 | ||
| PCT/EP2016/076952 WO2017077139A1 (en) | 2015-11-08 | 2016-11-08 | Combined pre- and pro-biotic composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500056A JP2019500056A (ja) | 2019-01-10 |
| JP2019500056A5 true JP2019500056A5 (ja) | 2019-12-19 |
| JP6918007B2 JP6918007B2 (ja) | 2021-08-11 |
Family
ID=57249812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543445A Active JP6918007B2 (ja) | 2015-11-08 | 2016-11-08 | 組合せプレバイオティクス及びプロバイオティクス組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200164009A1 (ja) |
| EP (1) | EP3370750A1 (ja) |
| JP (1) | JP6918007B2 (ja) |
| KR (1) | KR20180080256A (ja) |
| CN (1) | CN108883143A (ja) |
| AU (1) | AU2016348786B2 (ja) |
| BR (1) | BR112018009192B1 (ja) |
| CA (1) | CA3003775A1 (ja) |
| RU (1) | RU2768499C2 (ja) |
| WO (1) | WO2017077139A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018103808A1 (en) * | 2016-12-07 | 2018-06-14 | Vivox Aps | A fermented composition comprising a high content of one or more lactic acid bacterial strains and a method for making the composition and use thereof |
| EP3840578A1 (en) * | 2018-08-20 | 2021-06-30 | Fermbiotics Holding ApS | Improved human food product |
| CN109136131A (zh) * | 2018-08-27 | 2019-01-04 | 南昌大学 | 一株具有缓解结肠炎功效的鼠李糖乳杆菌及其应用 |
| US20210371886A1 (en) * | 2018-09-19 | 2021-12-02 | Fermentationexperts A/S | Process for controlling a fermentation process |
| WO2020058365A1 (en) * | 2018-09-19 | 2020-03-26 | Fermentationexperts A/S | Composition against resistant organisms (mrsa) |
| TWI693072B (zh) * | 2018-12-14 | 2020-05-11 | 大漢酵素生物科技股份有限公司 | 含有硫苷化合物的抗癌組合物及其用途 |
| US20220193169A1 (en) * | 2019-04-06 | 2022-06-23 | Fermentationexperts A/S | Anti-inflammatory composition |
| TWI766184B (zh) * | 2019-09-04 | 2022-06-01 | 歐斐生 | 一種植物乳桿菌及其製備植物性凝態優格、改善腸道菌相的用途 |
| KR102662148B1 (ko) * | 2020-08-21 | 2024-05-02 | 주식회사 제노포커스 | 프리바이오틱스 또는 신바이오틱스를 유효성분으로 포함하는 면역증강용 조성물 |
| WO2022140409A1 (en) | 2020-12-23 | 2022-06-30 | Church & Dwight Co., Inc. | Compositions and methods to increase production of isothiocyanates |
| WO2024008597A1 (en) * | 2022-07-04 | 2024-01-11 | Alfasigma S.P.A. | Fermentation product for the treatment of inflammatory diseases |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0205647D0 (en) * | 2002-03-11 | 2002-04-24 | Danisco Cultor Niebull Gmbh | Method of improving food fermentation procedures |
| FI116878B (fi) * | 2003-02-21 | 2006-03-31 | Maa Ja Elintarviketalouden Tut | Glukosinolaattien entsymaattisen hajottamisen ohjaaminen maitohappobakteerin avulla |
| WO2005100614A1 (en) * | 2004-04-15 | 2005-10-27 | Chr. Hansen A/S | Method for reducing the content of pathogenic organisms present in food materials |
| JP2006298871A (ja) * | 2005-04-25 | 2006-11-02 | Otaka Koso Kk | 植物エキス発酵液の方法、その方法による植物エキス発酵液並びに哺乳動物の治療方法 |
| JP5626970B2 (ja) * | 2010-07-05 | 2014-11-19 | 株式会社 越後薬草 | ミネラル吸収促進剤 |
| DE102012100466A1 (de) * | 2011-04-21 | 2012-10-25 | Hochschule Fulda | Anlage und Verfahren zur Herstellung eines proteinreichen fettarmen pflanzlichen Produktes aus einem Presskuchen und Verwendung eines proteinreichen fettarmen pflanzlichen Produktes |
| DK177482B1 (en) | 2011-09-02 | 2013-07-08 | Fermentationexperts As | Method of manufacturing a fermented dry feed using a spin flash dryer |
| JP5390589B2 (ja) * | 2011-12-27 | 2014-01-15 | 農業生産法人株式会社 熱帯資源植物研究所 | 血管新生阻害剤 |
| JP5571650B2 (ja) * | 2011-12-27 | 2014-08-13 | 農業生産法人株式会社 熱帯資源植物研究所 | 非アルコール性脂肪性肝疾患および／または非アルコール性脂肪肝炎の治療薬 |
| WO2014131422A2 (en) * | 2013-02-28 | 2014-09-04 | Fermentationexperts A/S | Fermented rapeseed feed ingredient |
| CN103190626B (zh) * | 2013-04-17 | 2014-12-03 | 肖天存 | 治疗口腔溃疡的果蔬食品及其制备方法 |
| PL3021687T3 (pl) | 2013-06-28 | 2020-01-31 | Fermentationexperts A/S | Kompozycje zawierające sfermentowane wodorosty morskie i/lub algi |
| CN104543811B (zh) * | 2013-10-21 | 2018-05-15 | 广州博能生物科技有限公司 | 提高免疫力的天然复合粉及其制备方法和应用 |
| CN104273404A (zh) * | 2014-10-10 | 2015-01-14 | 安徽省农业科学院畜牧兽医研究所 | 一种微生物固态发酵菜籽饼粕脱毒的方法 |
-
2016
- 2016-11-08 BR BR112018009192-8A patent/BR112018009192B1/pt active IP Right Grant
- 2016-11-08 CA CA3003775A patent/CA3003775A1/en active Pending
- 2016-11-08 CN CN201680065161.6A patent/CN108883143A/zh active Pending
- 2016-11-08 RU RU2018121036A patent/RU2768499C2/ru active
- 2016-11-08 US US15/774,479 patent/US20200164009A1/en not_active Abandoned
- 2016-11-08 KR KR1020187015036A patent/KR20180080256A/ko not_active Application Discontinuation
- 2016-11-08 WO PCT/EP2016/076952 patent/WO2017077139A1/en active Application Filing
- 2016-11-08 JP JP2018543445A patent/JP6918007B2/ja active Active
- 2016-11-08 AU AU2016348786A patent/AU2016348786B2/en active Active
- 2016-11-08 EP EP16791604.8A patent/EP3370750A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500056A5 (ja) | ||
| US10449222B2 (en) | Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur | |
| RU2018121036A (ru) | Комбинированная пре- и пробиотическая композиция | |
| US20210000885A1 (en) | Method for Reducing the Likelihood of Developing Bladder or Colorectal Cancer in an Individual Human Being | |
| US20210283196A1 (en) | Method for Treating an Individual Suffering from a Chronic Infectious Disease and Cancer | |
| JP2021078504A5 (ja) | ||
| US11529379B2 (en) | Method and system for reducing the likelihood of developing colorectal cancer in an individual human being | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| JP2019048857A5 (ja) | ||
| Alexandre et al. | Probiotics: a new way to fight bacterial pulmonary infections? | |
| JP2018039833A5 (ja) | ||
| HRP20191096T1 (hr) | Sastavi koje sadrže bakterijske blautia sojeve za liječenje visceralne hipersenzitivnosti | |
| WO2018013583A3 (en) | Medicinal vaginal lactobacillus cocktail | |
| BR112018005195A2 (pt) | lactobacillus plantarum lc27, composição farmacêutica para a prevenção ou tratamento de uma ou mais doenças, composição alimentícia para a prevenção ou tratamento de uma ou mais doenças, método de prevenção ou tratamento de uma ou mais doenças, e uso de uma composição que compreende lactobacillus plantarum lc27 | |
| JP2017518370A5 (ja) | ||
| Peng et al. | Polyphenols and tri-terpenoids from Olea europaea L. in alleviation of enteric pathogen infections through limiting bacterial virulence and attenuating inflammation | |
| O'Sullivan et al. | Protecting the outside: Biological tools to manipulate the skin microbiota | |
| RU2016143195A (ru) | Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза | |
| GB2605271A (en) | Compositions of probiotics and biomass and methods for promoting health in a subject | |
| Silva et al. | Probiotics for prevention and treatment of candidiasis and other infectious diseases: Lactobacillus spp. and other potential bacterial species | |
| CN113564068B (zh) | 植物乳杆菌1201及其在制备抑制鼠伤寒沙门氏菌产品中的应用 | |
| KR20170045247A (ko) | 유산균 함유 조성물 | |
| BRPI0924418A2 (pt) | composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade | |
| Thi et al. | Therapeutic effect of heat-killed Lactobacillus plantarum L-137 on the gut health and growth of broilers | |
| JP2019156793A5 (ja) |